EBQ:RE-LY: Difference between revisions
Ostermayer (talk | contribs) (Created page with "==Clinical Question== ==Conclusion== ==Major Points== ==Inclusion Criteria== ==Exclusion Criteria== ==Interventions== ==Outcome== ===Primary Outcomes=...") |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{JC info | |||
| title=Dabigatran versus warfarin in patients with atrial fibrillation | |||
| abbreviation=RE-LY | |||
| expansion=Randomized Evaluation of Long-Term Anticoagulation Therapy | |||
| published=2009 | |||
| author=Connolly SJ, et al | |||
| journal=The New England Journal of Medicine | |||
| year=2009 | |||
| volume=361 | |||
| issue=12 | |||
| pages=1139-51 | |||
| pmid=19717844 | |||
| fulltexturl=http://www.nejm.org/doi/full/10.1056/NEJMoa0905561 | |||
| pdfurl=http://www.nejm.org/doi/pdf/10.1056/NEJMoa0905561 | |||
}} | |||
==Clinical Question== | ==Clinical Question== | ||
Revision as of 05:58, 3 November 2013
incomplete Journal Club Article
Connolly SJ, et al. "Dabigatran versus warfarin in patients with atrial fibrillation". The New England Journal of Medicine. 2009. 361(12):1139-51.
PubMed Full text PDF
PubMed Full text PDF